Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

November 30, 2013

Conditions
NeurotoxicityPainUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

lamotrigine

OTHER

Placebo

Trial Locations (23)

29303

CCOP - Upstate Carolina, Spartanburg

32224

Mayo Clinic - Jacksonville, Jacksonville

45429

CCOP - Dayton, Dayton

48106

CCOP - Michigan Cancer Research Consortium, Ann Arbor

54301

CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay

55416

CCOP - Metro-Minnesota, Saint Louis Park

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

Coborn Cancer Center, Saint Cloud

57104

CCOP - Sioux Community Cancer Consortium, Sioux Falls

57709

Rapid City Regional Hospital, Rapid City

61801

CCOP - Carle Cancer Center, Urbana

68106

CCOP - Missouri Valley Cancer Consortium, Omaha

85259

Mayo Clinic Scottsdale, Scottsdale

96813

MBCCOP - Hawaii, Honolulu

30342-1701

CCOP - Atlanta Regional, Atlanta

61615-7828

CCOP - Illinois Oncology Research Association, Peoria

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1854

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology Associates at June E. Nylen Cancer Center, Sioux City

67214-3882

CCOP - Wichita, Wichita

58501-5505

Cancer Care Center at Medcenter One Hospital, Bismarck

43623-3456

CCOP - Toledo Community Hospital, Toledo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00068445 - Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | Biotech Hunter | Biotech Hunter